Efficacy and tolerance of hyperthermic intravesical chemotherapy (HIVEC) according to the number of instillations administered-Reference-Cited by-同舟云学术

Efficacy and tolerance of hyperthermic intravesical chemotherapy (HIVEC) according to the number of instillations administered

Published:2024-09-11 Issue:1 Volume:42 Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Gabriel Pierre-Etienne,Pignot Géraldine,Baboudjian Michael,Lebacle Cédric,Chamouni Alexandre,Lechevallier Eric,Irani Jacques,Tillou Xavier,Waeckel Thibaut,Monges Arnaud,Walz Jochen,Gravis Gwenaelle,Duperron Céline,Carpentier Xavier,Klein Clément,Masson-Lecomte Alexandra

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00345-024-05219-3.pdf

Reference23 articles.

1. Cancer today [cité 26 avr 2022]. Disponible sur: http://gco.iarc.fr/today/home

2. Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL et al (2022) European Association of Urology Guidelines on non-muscle-invasive bladder Cancer (Ta, T1, and carcinoma in situ). Eur Urol janv 81(1):75–94

3. Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR et al (2016) Diagnosis and treatment of non-muscle invasive bladder Cancer: AUA/SUO Guideline. J Urol oct 196(4):1021–1029

4. Oddens J, Brausi M, Sylvester R, Bono A, van de Beek C, van Andel G et al (2013) Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Eur Urol mars 63(3):462–472

5. Maibom SL, Joensen UN, Poulsen AM, Kehlet H, Brasso K, Røder MA (2021) Short-term morbidity and mortality following radical cystectomy: a systematic review. BMJ Open Avr 11(4):e043266